Sale of 400 shares at $288.9792 per share.
Reporting Person Reardon Andrew · Officer Title CLO & Secretary · Transaction Code S
Traded Sep 3, 2026 · Disclosed Sep 8, 2026
Source: SEC Form 4 · 0002001011-26-000137 · filed 2026-09-08 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "LIGAND PHARMACEUTICALS INC (LGND)." Disclosed 2026-09-08. https://desqlong.com/cards/0002001011-26-000137-5 (retrieved 2026-09-26).